SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as a potential solution to increase transaction speeds and enhance regulatory compliance in blockchain, with some community members suggesting it could complement larger crypto projects like NVDA, SUI, and BTC. Its focus on institutional financial infrastructure and integrations with companies like Stripe are also key talking points. However, some users express concern regarding the project.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp ($UAMY) is trending as conversations revolve around its potential role in securing domestic antimony supply, a critical mineral for defense and technology. Community members are discussing the company's contracts with the U.S. military, its production capacity, and potential government support or stake. Some are speculating about a potential merger or acquisition with other materials companies, while others debate the company's valuation and future prospects.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending as investors evaluate its solid earnings and future growth potential, particularly after its recent Nasdaq listing announcement and focus on e-commerce and AI integration. The community is discussing the stock's defensive qualities amid broader market uncertainty, with some analysts raising price targets. Conversations also highlight Walmart's potential competition with Amazon and its impact on smaller retailers.

Avalanche is a high throughput smart contract blockchain platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is trending as community members discuss its potential alongside emerging Layer 1 solutions like Keeta, particularly regarding high-throughput capabilities and institutional adoption. Community talking points highlight Avalanche's subnet architecture versus Keeta's focus on compliance-ready financial infrastructure. Keeta's integration with Stripe's Bridge for fiat on/off-ramps is also sparking interest as a catalyst for institutional flows.

Americas Gold & Silver Corp. engages in the acquisition, exploration, development, and exploration of mineral resource properties. It operates through the following segments: Cosalá Operations, Galena Complex, Relief Canyon, and Corporate and Other. The Cosalá Operations segment operates in Mexico. The Galena Complex and Relief Canyon segments focuses on the United States. The company was founded by Peter Jude Hawley on May 12, 1998 and is headquartered in Toronto, Canada.

Americas Gold and Silver Corp

Americas Silver Corp

Americas Silver Corp is trending as silver prices surge, sparking discussions about the company's potential growth and profitability. Community members are focused on its antimony production and the possibility of government funding, as well as speculation regarding future mergers and acquisitions. The rising silver prices and the company's strategic positioning are creating optimism about its long-term prospects.

Advisorshares Trust - AdvisorShares MSOS 2x Daily ETF

AdvisorShares MSOS Daily Leveraged ETF

MSOX is trending as traders discuss the potential impact of cannabis rescheduling, with some citing Trump's recent comments as a possible catalyst. The community is weighing the risks and rewards of this leveraged ETF, with many expressing confidence in a sector-wide rally. However, some traders remain cautious, pointing to historical volatility and potential reverse splits.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FCEL is trending as investors discuss its potential role in powering AI data centers using natural gas and carbon capture technology, particularly following positive mentions from ExxonMobil's recent earnings call. Community members are weighing the company's prospects against competitors like Bloom Energy, with some anticipating significant upside if FCEL secures major contracts in the expanding AI energy market. Discussions also include the stock's volatile history and the impact of past dilutions on its current valuation.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending amid speculation around potential cannabis rescheduling, with investors awaiting news from the Supreme Court and keeping an eye on Trump's next move. Community members are discussing the potential impact of rescheduling on profitability and institutional investment, while also debating which cannabis companies stand to benefit most. The conversation is also focused on the sector's history of volatility and the potential for a significant rally if rescheduling occurs.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending amid discussions about its role in AI data centers, particularly in relation to Nvidia. Community members are weighing its potential for growth in high-power markets and noting its partnerships. Some traders are closely watching for a breakout, while others express concerns about revenue and insider selling.

Kodiak AI, Inc. is a provider of AI-powered autonomous vehicle technology designed to help tackle some of the toughest driving jobs. Its solutions address the critical problem of safely transporting goods in the face of unprecedented supply chain challenges. The company was founded in 2018 and is headquartered in Mountain View, CA.

Kodiak AI Inc.

Kodiak AI Inc. - Ordinary Shares - Class A

Kodiak AI (KDK) is trending as investors discuss potential short squeezes, low float, and high borrow fees, while also awaiting upcoming earnings and potential news catalysts.  Community members are pointing to analyst upgrades, government contracts, and institutional interest, including recent activity from ARK Invest, as reasons for optimism.  Some are also highlighting the company's position in the autonomous trucking sector and comparing it to competitors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tarsus Pharmaceuticals (NASDAQ:TARS) Upgraded at Barclays

Barclays upgraded shares of Tarsus Pharmaceuticals to a "strong-buy" rating in a research note on Monday...

Norges Bank Acquires Shares of 471,354 Tarsus Pharmaceuticals, Inc. $TARS

Norges Bank bought a new position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Rating of "Moderate Buy" by Analysts

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine research firms that are covering the company, MarketBeat Ratings...

Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 12-Month High - Here's What Happened

Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 1-Year High - Here's Why...

Quantbot Technologies LP Purchases 24,319 Shares of Tarsus Pharmaceuticals, Inc. $TARS

Quantbot Technologies LP lifted its position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) by 151.8% during the 2nd quarter, according to the company in its most recent Form...

Virtus Investment Advisers LLC Buys 3,827 Shares of Tarsus Pharmaceuticals, Inc. $TARS

Virtus Investment Advisers LLC boosted its stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) by 54.5% during the second quarter, according to the company in its most recent filing...

Tarsus Pharmaceuticals (NASDAQ:TARS) Hits New 1-Year High - Here's What Happened

Tarsus Pharmaceuticals (NASDAQ:TARS) Reaches New 12-Month High - What's Next...

Universal Beteiligungs und Servicegesellschaft mbH Has $2.10 Million Holdings in Tarsus Pharmaceuticals, Inc. $TARS

Universal Beteiligungs und Servicegesellschaft mbH grew its position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) by 46.2% in the second quarter, according to its most recent filing...

AlphaCore Capital LLC Takes $490,000 Position in Tarsus Pharmaceuticals, Inc. $TARS

AlphaCore Capital LLC bought a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the...

Mizuho Begins Coverage on Tarsus Pharmaceuticals (NASDAQ:TARS)

Mizuho initiated coverage on shares of Tarsus Pharmaceuticals in a report on Thursday. They set an "outperform" rating and a $100.00 target price on the stock...

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. It is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.08	--	--	N/A
Q3 '25	-$0.35	-$0.30	14.14%	BEAT
Q2 '25	-$0.38	-$0.48	-26.79%	MISSED
Q1 '25	-$0.73	-$0.64	12.31%	BEAT
Q4 '24	-$0.70	-$0.60	14.41%	BEAT

TARS
Tarsus Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest TARS News

TARSTarsus Pharmaceuticals Inc